跳至主要内容
临床试验/NCT04289428
NCT04289428撤回不适用

Evaluation of Novel Point of Care Hepatitis B Diagnostic Assays

Kirby Institute1 个研究点 分布在 1 个国家开始时间: 2022年1月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Sensitivity and specificity of the Xpert® HBV DNA fingerstick point of care assay

研究概览

简要总结

Evaluation of novel point of care Hepatitis B diagnostic assays.

详细描述

This study aims to evaluate the sensitivity of the following novel assays for evaluation of HBV infection and assessment of treatment eligibility;

  • GeneXpert HBV DNA via Fingerstick testing,
  • Dried Blood Spot based HBV DNA
  • Point of care ALT.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Have voluntarily signed the informed consent form.
  • 18 years of age or older.
  • HBsAg positive
  • Part A: Not currently on antiviral therapy for HBV and HBV DNA detectable OR Part B: Stable on HBV antiviral therapy for at least 3 months with HBV DNA < 20 IU/ml

排除标准

  • Inability or unwillingness to provide informed consent or abide by the requirements of the study.

结局指标

主要结局

Sensitivity and specificity of the Xpert® HBV DNA fingerstick point of care assay

时间窗: Through study completion, an average of 1 year

To evaluate the sensitivity and specificity of the Xpert® HBV DNA point of care assay from finger-stick whole blood samples compared to plasma samples collected via venipuncture and tested on the Roche COBAS AmpliPrep/COBAS TaqMan HBV (CAP/CTM HBV) V2 assay.

次要结局

  • Sensitivity and specificity of the point of care ALT(Through study completion, an average of 1 year)
  • Sensitivity and specificity of the Xpert® HBV DNA point of care assay on dried blood spots(Through study completion, an average of 1 year)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验